Pulmatrix, Inc(NASDAQ:PULM) 
Pulmatrix, Inc., a clinical stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled Small Particles Easily Respirable a...
Website: http://pulmatrix.com
Founded: 2003
Full Time Employees: 22
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.00
H 6.00
L 5.25
C 5.40
V 36,848
10EMA 5.40
20EMA 5.40
60EMA 5.40
120EMA 5.40
250EMA 5.40